Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
Comparisons of the bone marrow and serum acid phosphatase values obtained by counter-immunelectrophoresis and the Roy biochemical test were made in 72 patients with and in 13 patients without prostatic cancer. The counter-immunoelectophoresis test, when positive at more than 1 international unit per liter, showed only 4.4 per cent falsely positive results. The Roy biochemical test, which used sodium thymolphthalein monophosphate as the substrate, had 65 per cent falsely positive bone marrow acid phosphatase levels. Conflicting reports regarding the value of bone marrow acid phosphatase determinations in patients with prostatic cancer result from the use of non-specific substrates in biochemical methods for measurement and from the trauma incidental to bone marrow aspiration, which releases many non-prostatic acid phosphatase enzymes. The use of immunoassay such as counter-immunoelectrophoresis minimizes this source of error.
D000135:Acid Phosphatase / Q000097:blood / Q000378:metabolism*; D001853:Bone Marrow / Q000201:enzymology*; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary; D004796:Clinical Enzyme Tests; D003378:Counterimmunoelectrophoresis; D005189:False Positive Reactions; D006801:Humans; D007122:Immunoelectrophoresis; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis*
D000135:Acid Phosphatase